JFGIW
CAPR icon

Johnson Financial Group Inc (Wisconsin)’s Capricor Therapeutics CAPR Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31 Buy
+1
New +$27 ﹤0.01% 875

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s CAPR Position: Q1 2026 in Review

Johnson Financial Group Inc (Wisconsin) opened a new position in Capricor Therapeutics (CAPR) in Q1 2026: 1 share worth $31. The stake represents ﹤0.01% of the portfolio and ranks #875 among its holdings.

177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • Johnson Financial Group Inc (Wisconsin) held 1 share of Capricor Therapeutics worth $31 as of Q1 2026.
  • Capricor Therapeutics was a new Johnson Financial Group Inc (Wisconsin) position in Q1 2026.
  • Capricor Therapeutics made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q1 2026, its #875 holding.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q1 2026, filed 7 May 2026.